BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33856264)

  • 1. Hypoxia-inducible factor-1α cooperates with histone Lys methylation to predict prognosis in esophageal squamous cell carcinoma.
    Shen X; Li Y; Xu Y; Liu M; Zhang Q; Yin R; Zhou M; Lin S; Fan H
    Biomark Med; 2021 May; 15(7):509-522. PubMed ID: 33856264
    [No Abstract]   [Full Text] [Related]  

  • 2. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
    Zhou M; Li Y; Lin S; Chen Y; Qian Y; Zhao Z; Fan H
    Dig Dis Sci; 2019 Aug; 64(8):2147-2157. PubMed ID: 30788686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma.
    Zhao X; Tang YP; Wang CY; Wu JX; Ye F
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3351-3357. PubMed ID: 31081089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High methylation levels of histone H3 lysine 9 associated with activation of hypoxia-inducible factor 1α (HIF-1α) predict patients' worse prognosis in human hepatocellular carcinomas.
    Qian Y; Li Y; Zheng C; Lu T; Sun R; Mao Y; Yu S; Fan H; Zhang Z
    Cancer Genet; 2020 Jul; 245():17-26. PubMed ID: 32534446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of hypoxia-inducible factor 1α, and its correlation with p53 and vascular endothelial growth factor expression in resectable esophageal squamous cell carcinoma.
    Shao N; Han Y; Song L; Song W
    J Cancer Res Ther; 2020; 16(2):269-275. PubMed ID: 32474512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma.
    Macedo-Silva C; Miranda-Gonçalves V; Lameirinhas A; Lencart J; Pereira A; Lobo J; Guimarães R; Martins AT; Henrique R; Bravo I; Jerónimo C
    Cell Death Dis; 2020 Dec; 11(12):1068. PubMed ID: 33318475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR4 promotes the growth and metastasis of esophageal squamous cell carcinoma as a critical downstream mediator of HIF-1α.
    Wu X; Zhang H; Sui Z; Gao Y; Gong L; Chen C; Ma Z; Tang P; Yu Z
    Cancer Sci; 2022 Mar; 113(3):926-939. PubMed ID: 34990040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of HIF-1α and esophageal squamous cell carcinoma (ESCC) risk.
    Sun G; Hu W; Lu Y; Wang Y
    Pathol Oncol Res; 2013 Oct; 19(4):685-93. PubMed ID: 23658132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patients.
    Zhang L; Ye SB; Li ZL; Ma G; Chen SP; He J; Liu WL; Xie D; Zeng YX; Li J
    Int J Clin Exp Pathol; 2014; 7(7):3887-97. PubMed ID: 25120765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Methoxyestradiol promotes radiosensitivity of esophageal squamous cell carcinoma by suppressing hypoxia-inducible factor-1α expression.
    Lu YR; Song J; Zhabihula BX; Zhang JR
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10785-10795. PubMed ID: 31858546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma.
    Yang Z; Ni W; Cui C; Qi W; Piao L; Xuan Y
    Hum Pathol; 2018 Nov; 81():148-156. PubMed ID: 30031102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasculogenic mimicry and aberrant expression of HIF-lα/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma.
    Chai DM; Bao ZQ; Hu JG; Ma L; Feng ZZ; Tao YS
    J Huazhong Univ Sci Technolog Med Sci; 2013 Jun; 33(3):385-391. PubMed ID: 23771665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
    Du F; Guo T; Cao C
    Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients.
    Liu F; Gu L; Cao Y; Fan X; Zhang F; Sang M
    Biomarkers; 2016; 21(1):80-90. PubMed ID: 26631178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles carrying miR-655-3p inhibit the development of esophageal cancer by regulating the expression of HIF-1α via a LMO4/HDAC2-dependent mechanism.
    Chen M; Xia Z; Deng J
    Cell Biol Toxicol; 2023 Aug; 39(4):1319-1339. PubMed ID: 36222945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation Patterns of Lys9 and Lys27 on Histone H3 Correlate with Patient Outcome in Gastric Cancer.
    Li Y; Guo D; Sun R; Chen P; Qian Q; Fan H
    Dig Dis Sci; 2019 Feb; 64(2):439-446. PubMed ID: 30350241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
    Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
    World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
    Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
    Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
    Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma.
    Shirakawa M; Fujiwara Y; Sugita Y; Moon JH; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Mori M; Doki Y
    Oncol Rep; 2012 Apr; 27(4):940-6. PubMed ID: 22200953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.